BindingDB logo
myBDB logout

12 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
25406853 72 Selective inhibitors of protein methyltransferases.EBI Icahn School of Medicine at Mount Sinai
25746813 37 SAH derived potent and selective EZH2 inhibitors.EBI Pfizer Inc.
25032507 43 Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.EBI University of North Carolina at Chapel Hill
24387159 36 Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cells.EBI Sapienza Universit£ di Roma
23445220 50 Exploiting an allosteric binding site of PRMT3 yields potent and selective inhibitors.EBI University of North Carolina at Chapel Hill
21780790 65 Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines.EBI University of North Carolina at Chapel Hill
18800048 4 Chemical probes for histone-modifying enzymes.EBI Johns Hopkins UniversitySchool of Medicine
20614940 76 Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines.EBI University of North Carolina at Chapel Hill
19891491 26 Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a.EBI University of North Carolina